The directional migration of cells within multicellular organisms is governed by gradients of both chemical attractants and repellents in diverse processes, including leukocyte trafficking and neuronal pathfinding in vivo. These complex extracellular environments direct the orchestrated bidirectional trafficking of leukocytes between the vasculature and tissues. Substantial progress has been made in dissecting the molecular mechanisms involved in orchestrating the directed movement of leukocytes into host tissues; however, less is known about the reverse migration of leukocytes from the tissues to the vasculature. In this article, we discuss the functional interplay between chemoattraction and chemorepulsion in the bidirectional movement of cells in complex in vivo environments, and we describe how these mechanisms influence both normal physiology and human disease.
The directional migration of cells within multicellular organisms is governed by gradients of both chemical attractants and repellents in diverse processes, including leukocyte trafficking and neuronal pathfinding in vivo. These complex extracellular environments direct the orchestrated bidirectional trafficking of leukocytes between the vasculature and tissues. Substantial progress has been made in dissecting the molecular mechanisms involved in orchestrating the directed movement of leukocytes into host tissues; however, less is known about the reverse migration of leukocytes from the tissues to the vasculature. In this article, we discuss the functional interplay between chemoattraction and chemorepulsion in the bidirectional movement of cells in complex in vivo environments, and we describe how these mechanisms influence both normal physiology and human disease.
Understanding reverse leukocyte migration
Immune responses involve the orchestrated trafficking of leukocytes between the vasculature and tissues. Leukocyte migration within lymphoid and non-lymphoid tissues requires not only dynamic interactions between cells and the extracellular matrix (ECM) but also the recognition of chemoattractants and chemorepellents, and directed migration in response to these factors (see Box 1) [1] [2] [3] [4] . The classic steps of leukocyte trafficking within the body involve leukocyte movements through the vasculature, firm adhesion to the endothelium, and subsequent transendothelial migration into tissues. This directed movement from the vasculature to the tissues is probably orchestrated by a complex array of soluble factors in combination with the ECM environment. Substantial progress has been made in dissecting the molecular composition of the factors involved in orchestrating the directed movement of leukocytes into host tissues, and this has been reviewed extensively [4, 5] . However, less is understood about what regulates the reverse movement of leukocytes from tissues to the vasculature or lymphatics, a process known as reverse chemotaxis or intravasation ( Figure 1 and Box 1) [6] . This process of reverse migration is a key component of normal physiological processes, including the trafficking of leukocytes from the bone marrow to the vasculature, and the process of lymphocyte egress from lymphoid tissue to the vasculature or lymphatics during immune surveillance. The evidence reviewed here supports the existence of both chemoattractants and chemorepellents that guide this process. Studies of leukocyte reverse migration are informed by an increased understanding of how the directional decisions to move either toward or away from a specific agent guide axonal growth cones during development. Reverse migration is also a likely component of pathologic conditions, including tumor invasion and metastasis, and the dissemination of intracellular pathogens from infected tissues into the vasculature.
Recent studies implicate reverse chemotaxis and reverse transmigration of leukocytes in the resolution of inflammatory responses involving the innate immune system. For example, blocking junctional adhesion molecule C (JAM-C) from endothelial contact sites reduced the number of monocytes at extravascular spaces by increasing reverse transmigration of monocytes across the endothelium [7] . The use of mammalian systems and intravital imaging has provided further evidence for reverse migration in vivo. A recent study demonstrated that rising concentrations of cytokine-induced neutrophil chemoattractant-1 (CINC-1, the rat orthologue of human interleukin ) initially serve as a neutrophil chemoattractant in mesentery, causing visualized neutrophil extravasation [8] . However, increasing concentrations ultimately result in neutrophil movement in the opposite direction -back toward the venule wall. Time-lapse imaging in zebrafish embryos reveals that neutrophil reverse chemotaxis from sites of tissue wounding back to the vasculature is a key mechanism by which inflammation is resolved after acute injury [9] , and this process can be impaired under some conditions of chronic inflammation [10] . Thus, reverse migration of leukocytes can be governed in vivo by competing gradients of chemical attractants and/or repellents, and potentially bidirectional cues such as chemokines,.
Here, we review what is known about the molecular mechanisms that mediate the response of cells to chemoattractants, chemorepellents and bidirectional cues that can either attract or repel, or to the effects of competing gradients. The aim of our review is, first, to provide insight into cellular processes that mediate the reverse movement of leukocytes in complex in vivo environments and, second, to describe the implications of these mechanisms for both normal physiology and human disease.
Signaling in chemoattraction and chemorepulsion
Chemotaxis, the directional motility in response to chemical gradients, is a fundamental and universal mechanism amongst living organisms, from prokaryotes to higher vertebrates [11] . Gradient sensing enables a cell to respond to a gradient of a specific chemokinetic agent in its environment [12] . This gradient signal is received through specific receptors on the cell surface and is subsequently transduced through intracellular signaling machinery to generate a coherent response. The net result of this response is to cause the cell to move up a gradient of a chemoattractant or down a gradient of a chemorepellent. The sensing and response mechanisms of both chemoattraction and chemorepulsion are found in both prokaryotes and higher eukaryotic cells. From a reductionist standpoint, chemoattraction and chemorepulsion are seen as contributing to the ability of a cell to find optimal surroundings for performing specific functions in vivo.
Chemoattraction has been studied extensively in prokaryotes and in simple and complex eukaryotes [11] . These studies have revealed a complex set of chemoattractantchemoreceptor interactions, intracellular signal transduction pathways and cell migratory processes, which together guide this directional choice [13] [14] [15] [16] . Furthermore, in higher vertebrates, chemoattraction plays significant roles in embryonic development, the development of vascular and neuronal structures, and the establishment Box 1. Definition of terms for leukocyte migration
The term chemotaxis is used in this review to describe all directional migration of leukocytes in response to a chemical stimulus. Chemoattraction results from the movement of leukocytes up a gradient and towards a peak concentration of a chemoattractant, whereas chemorepulsion results from migration down a gradient away from peak concentrations of the chemorepellent. The term 'fugetaxis' has been introduced into the scientific literature and is used interchangeably with the term chemorepulsion, but it is specifically used in the context of an agent that can either attract or repel cells depending on the concentration of the agent or context [27] . As in neuronal growth-cone biology, bidirectional cues exist for leukocyte populations and can serve as either chemoattractants or chemorepellents in a manner dependent upon concentration, receptor and/or cell type. Whereas transendothelial migration is generally applied to the extravasation of leukocytes from the vascular compartment into the tissues, the term reverse chemotaxis or migration describes the active movement of leukocytes from the tissue space back toward the vasculature [67] , and it is this process that is the focus of this review article. Figure 1 . Schematic of leukocyte bidirectional trafficking in response to inflammatory stimuli. (a) Leukocyte extravasation occurs in response to many inflammatory stimuli, including bacterial infection and tissue wounding. The stages of extravasation have been described in detail [4, 5] and involve the sequential activation of adhesion receptors on the leukocyte surface; for example, selectins mediate initial leukocyte rolling. Subsequently, firm adhesion is mediated by integrin cell surface receptors that enable the attachment and transmigration of the leukocyte across the endothelial surface. The final stage of the process involves the directed migration of leukocytes through tissues to the site of inflammation. (b) Leukocyte intravasation or reverse transmigration involves the reverse movement of leukocytes from tissues to the vasculature and their subsequent trafficking through the vasculature. This reverse transmigration is less well characterized and occurs during leukocyte trafficking and lymphocyte egress from the thymus. Recent evidence also indicates that leukocytes in zebrafish models undergo reverse transmigration during the resolution phase of the inflammatory response [9] . Less is understood about the mechanisms that regulate reverse transmigration, but cell surface receptors such as JAM-C are involved in regulating these processes during macrophage reverse transmigration [7] . The mechanisms that contribute to chemorepulsion and reverse transmigration are the focus of this article. 6 of an inflammatory or immune response to pathogens or tissue injury. Much of the progress in elucidating the mechanisms by which cells sense chemoattractants and migrate directionally toward them has benefited from using the genetic model system Dictyostelium discoideum [17] [18] [19] [20] .
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Chemotaxis involves two separate yet functionally linked events -gradient sensing and cell polarizationthat work synergistically to facilitate directional migration [17] [18] [19] . Directional sensing is the ability of a cell to detect gradients of chemoattractants. It involves the asymmetric recruitment of signaling molecules (e.g. phosphatidylinositol (3,4,5)-trisphosphate [PtdIns(3,4,5)P 3 ]) that mediate chemotaxis to the membrane adjacent to the highest concentration of chemoattractant ( Figure 2 ) [20] [21] [22] [23] [24] . Gradient sensing does not require cell polarization and occurs independently of actin polymerization. By contrast, cell polarization is an actin-dependent process that leads to the development of an asymmetric morphology and a leading edge characterized by the accumulation of actin and actinbinding proteins. The generation of a well-defined leading edge is regulated by the asymmetric localization and activation of key signaling molecules, including phosphoinositide 3-kinase (PI3K), phospholipase C (PLC), and Cdc42 and Rac, Rho GTPase family members that promote the localized nucleation and polymerization of actin [22, 24] . Deficiencies in the activities of these key signaling components at the leading and trailing edge of the cell result in the loss of cell polarity and reduced efficiency of chemotaxis.
A recent study suggests that D. discoideum is also instrumental in determining the mechanisms that mediate chemorepulsion. D. discoideum is repelled by substances secreted by starving cells, although the identity of these compounds remains unknown. A recent study suggests that chemorepellents -in this case cAMP analoguesinduce chemorepulsion by affecting the polarity of PLC and PI3K signaling [25] . Specifically, the chemorepellents induce localized inhibition of PLC and thereby the accumulation of PtdIns(4,5)P 2 , whereas PtdIns(3,4,5)P 3 concentrates at the side of the cell farthest from the Figure 2 . Schematic of the asymmetric polarization of signaling molecules during chemotaxis. Both D. discoideum and neutrophils are common model systems used to study chemotaxis. Substantial evidence supports the asymmetric activation of PI3K at the leading edge of both D. discoideum and neutrophils during directed cell migration. Both neutrophils and D. discoideum also have the localized activation of the small GTPases Rac and/or Cdc42 at the leading edge, which results in the subsequent activation of actin polymerization and pseudopod formation. The uropod contains the phosphatase PTEN (phosphatase and tensin homolog) [12] in both neutrophils and D. discoideum and recent evidence implicates a role for PI5K [67] and Rho signaling [68] at the uropod of neutrophils. chemorepellent and mediates pseudopod formation and reverse migration (Figure 3 ). These findings suggest that chemorepulsion in some cases might represent a reversal of polarity through pathways that are instrumental in normal chemotactic responses, such as the PLC and PI3K pathways. This represents a very exciting area for future investigation -one that will enable the dissection of key pathways that mediate signaling in response to chemorepellents.
Leukocytes, including T cells and neutrophils, can exhibit chemorepulsion or fugetaxis in response to chemokines that are generally considered to induce chemoattraction. For example, high concentrations of the chemokine, stromal cell-derived factor-1 (SDF-1 or CXCL12) induces chemorepulsion rather than chemoattraction [26] . T cell and neutrophil bidiretional migration in response to chemokines have revealed differential sensitivities of chemoattraction and chemorepulsion to protein kinase inhibitors. For instance, T cell chemoattraction, but not chemorepulsion, to SDF-1 is inhibited by the tyrosine kinase inhibitors, genistein and herbimycin [26] . Furthermore, PKC inhibition or perturbation of intracellular cAMP concentrations converts a neutrophil chemorepellant to a chemoattractant response [8, 27] . These findings support a model in which differential receptor occupancy, intracellular kinase activation and cyclic nucleotide concentrations determine the directional decision to move towards or away from a chemokine (Figure 4) . However, the precise molecular steps that govern the directional decision of leukocytes to respond to soluble factors by attraction or repulsion remain to be resolved. Further understanding of the mechanisms that regulate chemorepellent and chemottractive signaling might have an impact on the treatment of a wide variety of immune and inflammatory diseases.
Axon growth-cone guidance provides mechanistic insights into leukocyte reverse migration The balance between the action of chemorepellents and chemoattractants has emerged as a crucial component that guides the movements of neurons and their growing axons during pathfinding in the developing nervous system. Axon growth-cone guidance is the most well studied example of bidirectional cell movement in vertebrate systems. Many of the factors that mediate chemorepulsion can function as bidirectional cues that can either attract or repel. Such factors include netrins, semaphorins, slit ligands, and :PKC ratios, localization of Akt, Cdc42 and PKCz, to the leading edge, and RhoA-p160ROCK to the trailing edge associated with chemoattraction and chemorepulsion. 6 ephrins [28] [29] [30] [31] [32] . In axon growth cones, the signal transduction mechanism for attraction is molecularly distinct from that guiding repulsion, and these agents can serve as a chemoattractant or chemorepellent depending on the developmental stage of the neuron and the specific intracellular signaling cascades that are induced [28, 33] . These agents cause a growth cone to migrate toward or away from a bidirectional cue depending on the context. An additional aspect of the diversity of migratory responses in axons is that a repellent response can occur as a result of either diffusible or ECM-bound chemorepellents. For example, both matrix-bound and soluble repellents play a significant role in the development of somites [34] .
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There is a growing understanding of the signaling pathways that differentiate axon growth-cone chemoattraction from chemorepulsion, and this understanding might lend clues to similar processes governing leukocyte migration into and out of tissues [35] [36] [37] [38] [39] [40] [41] [42] . For example, several studies have revealed the mechanistic elements that distinguish between netrin-induced chemoattraction and chemorepulsion. Receptors for secreted netrins include DCC (deleted in colorectal cancer) and UNC5 homologues. Investigations using knockout mouse models have shown that the netrin receptor DCC mediates chemoattraction, whereas the DCC-UNC5 complex mediates chemorepulsion. Attractive signaling through DCC is mediated by the GDP-GTP exchange factor DOCK180 and the activation of the small GTPase Rac1 [43] . However, the ratios of cyclic AMP to cyclic GMP probably determine the decision to attract or repel -with high and low ratios being associated with attraction and repulsion, respectively, to netrin-1 [44] . PKCa activation and the resulting stimulation of UNC5 internalization is also important for favoring attraction over repulsion, because UNC5A internalization converts netrin-mediated chemorepulsion to attraction [45] . Previous studies have demonstrated that chemorepulsion depends on UNC5A, because UNC5A-null axons are not repelled. Furthermore, the change to chemoattraction requires the adaptor protein PICK1, because PICK1-null axons do not mediate chemoattraction after PKCa activation [45] . Hence, the conversion between repellent and attractant responses to netrin-1 is dependent on PKCa and PICK1. Mechanistic elements involved in second messenger signaling have been shown to influence the netrin-1 induced bidirectional axonal responses. In Xenopus spinal neurons, attraction is converted to repulsion by inhibition of cAMP or protein kinase A or by lowering intracellular levels of Ca 2+ [30] . PI3K, mitogen-activated protein kinase (MAPK) and PLC have been shown to influence this process [46] . Further studies of neuronal axon growth-cone adaptation have revealed consecutive phases of desensitization and resensitization in the presence of increasing basal concentrations of the guidance factor netrin-1 or brain-derived neurotrophic factor. Furthermore, previous studies have demonstrated that desensitization is accompanied by reduced Ca 2+ signaling [46] . By contrast, MAPK and local protein synthesis is associated with resensitization. These processes evidently enable the growth cone to re-adjust its sensitivity over a wide range of concentrations of netrin-1 [47] . The role of Ca 2+ in signaling the directional decision of growth cones has recently been a focus of attention. The activity of the transient receptor potential (TRP)-like channel in the growth cones of cultured Xenopus neurons is modulated by the chemoattractants netrin-1 and brain-derived neurotrophic factor [48] . Furthermore, independent of changes in intracellular signaling, the concentration or gradient of ligand can also influence the decision to attract or repel [45] . Finally, gradient structure can also influence the directional decision. A recent study demonstrated that steeper gradients of the semaphorin Sema 2A induce more chemorepulsion than shallow gradients do [49] .
Axon growth-cone chemorepulsion therefore involves specific ligand-receptor interactions and intracellular signaling events that are distinct from those governing chemoattraction. Furthermore, the developmental stage of the cell, gradient structure, Ca 2+ flux and the presence of diffusible or matrix-bound gradients of chemokinetic agents can determine the directional response. It is likely that aspects of the signaling cascade that differentiate repulsion from attraction in neuronal growth cones are conserved and might ultimately be relevant to leukocyte migration [35, 36, 50] .
Chemorepulsion in the immune system
There is growing evidence that chemorepulsion is probably a key mechanism involved in regulating leukocyte motility. Some of the cues that regulate neuronal chemorepulsion have also recently been implicated in regulating the responses of leukocytes to chemoattractants. As alluded to above, many of the chemoattractants and chemorepellents that affect neuronal cell migration, including netrins, semaphorins, slit ligands, and ephrins, have recently been implicated in the motility of immune cells [35, 36, 39, 40, 50] . An example of this conservation is the involvement of Slit, a secreted protein that mediates axonal chemorepulsion and which has also been shown to inhibit the directed migration of leukocytes in response to chemoattractants [51] . These findings indicate that secreted factors can serve as inhibitors of leukocyte chemotaxis and thereby alter the responsiveness of leukocytes in vivo. More recent studies indicate an association between Robo and the CXCR4 receptor on T cells and suggest that Slit-Robo modulates CXCR4-mediated chemotaxis through the regulation of downstream effector pathways, such as the Src and Lck kinase pathways [38] . In related studies, the guidance molecule netrin has been shown to bind to the netrin receptor UNC5b on leukocytes and to inhibit leukocyte chemotaxis both in vitro and in vivo [37] . Further studies suggest that other neuronal guidance cues, such as semaphorins, play important and diverse roles in immune function, including regulating the interactions between T cells and antigen-presenting cells [36] . Other factors might also provide chemorepulsive effects on immune cells, and these inhibitory effects might be regulated by the tissue microenvironment. An example includes the Ca 2+ -binding proteins S100A8 and S100A9, which have recently been reported to repel neutrophil motility; however, under conditions of oxidative stress, these factors lose their inhibitory functions, suggesting that this inhibitory function is neutralized [52] . Together, these recent reports suggest that leukocyte migration is regulated, in a manner
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Trends in Cell Biology Vol.18 No.6 analogous to the neuronal cells, by the balance of chemorepulsive and chemoattractive signals.
The other aspect of chemorepulsion in the immune system is the active migration of leukocytes away from a factor (e.g. a chemokine) that is normally considered to stimulate chemoattraction. Previous studies have reported that T cells can migrate away from a high concentration of the chemokine SDF-1 rather than be attracted by the lower concentrations of the same factor. This SDF-1-induced chemorepulsion is mediated by Ga i -mediated signaling, because the process is sensitive to pertussis toxin (PTX), suggesting that the concentration of ligand and receptor occupancy can influence directional decision-making [8, 26] . This might be in contrast to chemorepulsion in the nervous system, where the decision to attract or repel is generally made by the involvement of different receptors expressed on the cell surface -as is the case with the netrin-1-DCC-UNC5A complex. Similar results have been reported for directional migratory responses of primary human neutrophils to the chemokine IL-8 [8] . Intriguingly, perturbations of intracellular cyclic nucleotide concentrations in both T cells and neutrophils in the context of chemokine signaling alter directional decision making in these cells. This is analogous to the effects of cyclic nucleotide concentrations on axonal growth cone chemoattractant and chemorepellant responses to netrins [8, 26] .
A final component of the conservation between immune and neuronal cell chemorepulsion probably involves the contribution of Ca 2+ signaling. However, the role of Ca 2+ signals during the directed migration of leukocytes is controversial, and probably plays a role in both positively and negatively regulating directed cell migration. For example, a recent study suggests that Ca 2+ influx is essential for the positive-feedback loop that promotes protrusion of the leading edge of macrophages [53] . Specifically, their findings implicate Ca 2+ in the enrichment of PKCa and activation of PI3K and F-actin polymerization at the leading edge of the cell. However, there is substantial evidence that robust Ca 2+ transients are associated with inhibition of cell motility and induction of a stop signal in T cells and other leukocytes [54] . Although Ca 2+ signaling has not been directly implicated in mediating chemorepulsion of leukocytes, it is possible that Ca 2+ -mediated cell stopping and loss of polarity precedes reverse migration in some contexts.
Reverse migration and the role of competing gradients of chemokinetic agents Leukocytes encounter a combination of chemorepellents and chemoattractants that modify their directional decision-making and trafficking in vivo. An additional component that influences the navigation of leukocytes in vivo is their response to competing gradients of chemoattractants that can induce distinct signaling pathways. A previous study has in fact demonstrated that there is an intracellular signaling hierarchy in the response to different chemoattractants [55] . For example, the authors showed that end-target chemoattractants (e.g. N-formyl-methionyl-leucyl-phenylalanine [fMLP]) that are found at sites of infection dominate over signals from intermediary chemoattractants, such as IL-8 and leukotriene B4 (LTB4). The end-target chemoattractants specifically activate signaling through p38 MAPK, whereas the intermediary signals induce PI3K activation, suggesting that these responses are separable. The authors also show that p38 MAPK inhibitors reverse this hierarchy by promoting preferential migration toward intermediary chemoattractants instead of toward end-target attractants, providing a mechanism to reverse migration in vivo by altering the activity of different intracellular signaling pathways.
Reverse migration in the context of immune cell development and trafficking: integrating retention, chemoattraction and chemorepulsion The thymus and other hematopoietic organs have proven to be interesting sites to examine reverse migration, because leukocyte populations that develop in these organs must, by the very nature of their developmental pathway, exit the anatomical site in which they develop to join the ranks of circulating leukocytes in the vasculature. Furthermore, lymphoid cell trafficking between tissue sites and secondary lymphoid organs also involves reverse migration from tissues into the vasculature or lymphatics. The role of chemoattraction in leukocyte development, maturation and function has been extensively studied [4] . However, the role that chemorepellents play in reverse migration in vivo is less well understood.
The study of thymic emigration has proven to be an interesting model system in which to study the directional cues that contribute to reverse migration. Thymocytes at full maturity migrate from the medulla or from other locations in the thymus, through the endothelium of post-endothelial venules and into the vasculature in a process of reverse migration. It is thought that chemokinetic agents, including chemokines that signal through Ga i protein-coupled receptors, are involved in thymic emigration, because this process was found to be sensitive to PTX [56] . The chemokine CCL19, which is highly expressed by endothelial venules in the thymic medulla, is thought to act as a chemoattractant for mature T-cells generated within the thymus, guiding thymic emigration into venules [57] . In addition, sphingosine 1-phosphate (S1P) and its receptor, S1PR, have been shown to play a significant role in thymic emigration, although the precise mechanism by which this is achieved remains controversial [58] [59] [60] . However, there is also evidence that the action of chemoattractants alone does not fully explain the process of thymic emigration. Studies of Cxcr4-knockout mice suggest that both intrathymic chemorepellents and extrathymic chemoattractants govern the egress of mature thymocytes from the thymus [27, 61] . In these studies, the use of the CXCR4 antagonist AMD3100 suppressed thymic emigration, which was only partially restored by the administration of extrathymic chemoattractant concentrations of S1P. Combinations of cell type-specific chemorepellents, chemoattractants and/or chemokinetic agents might therefore exist to guide the reverse migration of cells in the context of thymic emigration.
Studies using intravital microscopy to examine lymphocyte egress from secondary lymph nodes have recently confirmed that reverse migration plays a role in the trafficking of T cells from lymphoid tissue to intranodal vascular and lymphoid spaces [62, 63] . Although thymic studies imply a chemoattractant activity for S1P, these studies suggest that S1P serves as a 'gating' mechanism on endothelial cells, restricting the physical egress of T cells from the lymph node. These findings support a two-step model in which the gate is opened by S1P to permit reverse migration, whereas chemotactic or chemokinetic agents might also actively guide this process. A recent caveat to this hypothesis is raised by the finding that the selective S1PR agonist-antagonist FTY720 appears to block egress of T cells from the lymph node, and that this egress is restored if T cells are PTX-treated or are CCR7-deficient [64] . This suggests that CCR7 mediates a retention signal in the thymus. These findings support the view that reverse emigration of T cells into medullary venules within the lymph node is the default and can actually occur in the absence of GPCR signaling. This thereby raises questions regarding the specific and additional roles that extra lymphoid chemoattractants, intra-lymphoid chemorepellents and/or agents that stimulate chemokinesis play in the exit of T cells from lymphoid tissue into the vasculature.
Insights from zebrafish models of reverse leukocyte migration Recent studies suggest that cells of the innate immune system also exhibit reverse chemotaxis to resolve inflammatory responses in zebrafish embryos. Transgenic embryos expressing green fluorescent protein from the leukocyte-specific promoter of the gene encoding myeloperoxidase (MPO) enable the direct visualization of neutrophil responses in the context of acute and chronic injury in vivo [9] . Wounding of the zebrafish fin induces the robust recruitment of neutrophils and macrophages, which is resolved at least in part by the reverse chemotaxis of leukocytes to the vasculature [9, 65] . Interestingly, the motility to and from the vasculature shows similar speed and directionality, suggesting that the signals that induce forward and reverse chemotaxis are equally robust [9] . A future challenge will be to determine if similar reverse migration occurs in mammalian systems, and this might involve the use of intravital imaging. Although reverse chemotaxis of neutrophils has not been clearly shown in mammalian systems to date, this might be because of the limitations associated with the open systems used for intravital imaging. The nature of these systems has an impact on tissue homeostasis or bacterial content, thereby complicating data interpretation. The mechanisms that govern these bidirectional movements in zebrafish systems remain unknown but represent an attractive system for exploring the mechanisms that regulate leukocyte chemorepulsion or reverse migration to the vasculature in vivo. It is possible that this reverse migration is induced by competing gradients, or alternatively by the contribution of chemokinetic agents or chemorepellents at the wound site that induce the reverse migration back to the vasculature. In addition, as with thymic emigration, retention signals might be shown to play a role in regulating neutrophil reentry into the vasculature. These types of questions will be the focus of future investigations to decipher the complex factors that contribute to reverse chemotaxis in vivo.
Conclusion
In contrast to the mature and detailed study of leukocyte chemoattraction and forward transmigration, the study of leukocyte chemorepulsion and reverse migration is in its infancy. The initial provocative studies detailed above argue that exploration of the mechanisms controlling reverse chemotaxis is clearly warranted. What remains unclear is the nature of the precise chemokine and cytokine gradients and intracellular signaling processes that guide these processes in vivo. What is also potentially exciting is the role that chemorepulsion and reverse migration might play in physiological and pathological processes. The evidence implicates a role for a balance among chemoattraction, chemokinesis and chemorepulsion in the regulation of the emigration of leukocytes from sites in which they develop, including the bone marrow, thymus and lymph nodes. Similarly, the possibility that reverse leukocyte migration guided by chemorepellents and/or chemoattractants serves as a regulator of an overzealous inflammatory response is highly provocative and potentially paradigm shifting. Finally, we can also speculate about the involvement of reverse migration and chemorepulsion in a diverse range of pathological processes, including cancer and infectious diseases. For example, reverse migration and chemorepellents might play a role in the metastatic process, in which tumor cells emigrate from the primary tumor into the lymphatics or circulation [66] . Alternatively, reverse chemotaxis may contribute to the ability of cells that have been infected with intracellular pathogens (e.g. HIV-1 or cytomegalovirus) to exit tissue sites of primary infection and disseminate through the blood stream. The possibility that reverse migration plays a role in cancer and infectious diseases raises the prospect of developing new therapeutic approaches that antagonize reverse migration to limit dissemination. On the other hand, increasing reverse migration to resolve inflammation might be beneficial in the context of chronic inflammatory conditions, including autoimmune diseases and graft versus host disease. The challenge for future investigation will be to further define the mechanisms that regulate reverse migration, and to identify new targets for therapeutic intervention
